Research Article
NCCAM/NCI Phase 1 Study of Mistletoe Extract and Gemcitabine in Patients with Advanced Solid Tumors
Table 5
Pharmacokinetics of gemcitabine (cycle 1) and gemcitabine plus mistletoe (cycle 3).
| | Cycle 1 Median (25th%, 75th%) | Cycle 3 Median (25th%, 75th%) | value Signed rank test |
| Gemcitabine AUC (min * nmol/mL) | 664 (514, 870) | 670 (625, 851) | 0.97 | Gemcitabine Average Cp (nmol/mL) | 47.7 (42.7, 64.6) | 49.7 (45.7, 53.8) | 0.85 |
|
|